The main purpose of this study was to evaluate the between-instrument variation of the HPLC method for the measurement of total cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), VLDL-cholesterol (VLDL-C), chylomicron cholesterol (CM-C), LDL size, and HDL size. Furthermore, the accuracy of the HPLC was assessed for the determination of TC and HDL-C, compared with CDC reference methods. Methods: We used four HPLC instruments with different column-load numbers from 250 to 5000. For accuracy assessment of TC and HDL-C, we used the reference methods recommended by the CDC. Results: The values measured by the four instruments were highly correlated with each other (mean r ‫؍‬ 0.965), and the absolute mean differences were 4 -43 mg/L for TC, 4 -30 mg/L for HDL-C, 0 -48 mg/L for LDL-C, 7-66 mg/L for VLDL-C, 0 -7 mg/L for CM-C, 0.1-0.3 nm for LDL size, and 0 -0.1 nm for HDL size. For TC, the HPLC instruments showed high correlation and good agreement with the reference method: r ‫؍‬ 0.997; total error <6.6%; absolute mean bias <1.2%. For HDL-C, the results from the HPLC method were significantly higher
Numerous epidemiological studies have shown that longterm hyperlipidemia is associated with coronary heart disease. High blood cholesterol or increased LDL-cholesterol (LDL-C) 5 and decreased HDL-cholesterol (HDL-C) have received attention because of their links to the increased risk of atherosclerotic disease (1) (2) (3) . Small dense LDL, one of the subclasses of LDL, has an important clinical significance as well (4, 5 ) . Both quantitative and qualitative approaches to lipoproteins have been clinically required.
Lipoprotein particles are classified on the basis of their hydrated density, size, and electrophoretic mobility. Major lipoprotein classes have been defined according to their density. The separation and quantification of lipoproteins by ultracentrifugation is not suited to the clinical laboratory setting, however, because the method is time-consuming and requires special training and large sample volumes.
HPLC is a method for classifying and quantifying lipoproteins by particle size (6 ) . In the HPLC method, the lipoproteins separated by gel permeation columns (TSKgel LipopropakXL; Tosoh) are detected by an on-line enzymatic reaction for cholesterol. Chylomicron cholesterol (CM-C), VLDL-cholesterol (VLDL-C), LDL-C, HDL-C, and total cholesterol (TC) are calculated automatically by a computer (7 ) . The greatest advantages of the HPLC method are direct profiling of lipoproteins in small sample volumes, and rapid and simultaneous determination of their size distribution. For many epidemiological and clinical studies, a reliable and convenient technique is required to allow quantification and characterization of lipoprotein subclasses directly from serum samples.
Several studies have compared the analytical performance of the HPLC method for lipoproteins with established methods, including an automated enzymatic assay for TC (8 ) , and homogenous (9, 10 ) , precipitation (9 -11 ) , and sequential ultracentrifugation (7 ) methods for HDL-C. However, the interlaboratory or between-instrument variation of this assay has not been examined. Furthermore, it is necessary to assess the accuracy of the HPLC method in comparison with the reference method to establish traceability to the reference method recommended by CDC (12 ) .
The main purpose of this study was to evaluate the between-instrument variation for measurement of TC, HDL-C, LDL-C, VLDL-C, CM-C, LDL size, and HDL size. We also participated in the certification protocols provided by the CDC's Cholesterol Reference Method Laboratory Network to assess the accuracy of the TC and HDL-C assays.
Materials and Methods samples
For comparison studies, two series (groups A and B) of pooled serum samples were prepared at Osaka Medical Center for Cancer and Cardiovascular Diseases (OMC), an international member of the Cholesterol Reference Method Laboratory Network. Group A (n ϭ 50) and group B (n ϭ 46) samples had a balanced distribution of TC and HDL-C concentrations, respectively, and had triglyceride (TG) values within the reference interval. Each of the pooled serum samples was obtained over an ϳ2-week period from the daily pools, which consisted of fresh sera from fewer than four outpatients. Aliquots of these samples were kept at Ϫ80°C and shipped to our laboratories on dry ice.
For the TG interference study, serum samples (group C) were collected from hypertriglyceridemic patients (n ϭ 19) with serum TG concentrations Ͼ2000 mg/L at Osaka University Hospital after informed consent. Group C samples were kept at 4°C and analyzed within 10 days after sample collection.
Precision studies were performed using two different pooled sera (QC1 and QC2) stored at Ϫ80°C. QC1 and QC2 were prepared by the same procedure as described above and had TC values of 1370 and 2180 mg/L, respectively.
calibration material
An in-house pooled serum (lot no. 90920) was prepared as the calibration material for the HPLC method. This material was obtained by combining fresh sera from healthy volunteers after a 12-h fast. Reference values (1770 mg/L for TC and 653 mg/L for HDL-C) were assigned to this material, using the reference methods at OMC. Aliquots of the material were stored at Ϫ80°C.
hplc method
We used an automated TOSOH Lipoprotein Analytical System (Tosoh), which included an AS-8020 autosampler, CCPS and CCPM-2 pumps, and a UV-8020 detector (7 ) . Serum lipoproteins were separated using two connected columns (300 ϫ 7.5 mm) of TSKgel LipopropakXL (Tosoh) with TSKeluent LP-1 (Tosoh) as the elution buffer at a flow rate of 0.700 mL/min. Cholesterol was detected by an on-line enzymatic reaction through the mixing of the effluent from the columns with a commercial kit, Determiner L TC (Kyowa Medex). Reagents 1 and 2 of the commercial kit were continuously pumped at flow rates of 0.263 and 0.087 mL/min, respectively. The absorbance at 550 nm was continuously monitored after the enzymatic reaction at 45°C in a reactor coil (7.5 m ϫ 0.4 mm i.d.). A 5-L sample was injected at an interval of 16 min per sample. An in-house pooled serum (lot no. 90920) was used as the calibrator. HPLC profiles of the calibration material and a sample from a hyperlipidemic patient (TC, 3240 mg/L; TG, 14 460 mg/L) are shown in Fig. 1 . The cholesterol concentrations in the major lipoprotein classes were estimated from a linear calibration curve of the assigned TC value plotted against the total area with the calibrator, after automatic calculations of total area and individual areas corresponding to HDL, LDL, VLDL, and CM.
Calibration of columns was carried out using latex beads (Magsphere) 25 and 37 nm in diameter, and highmolecular weight calibrators (Pharmacia Biotech) containing thyroglobulin (17 nm), ferritin (12.2 nm), catalase (9.2 nm), albumin (7.1 nm), and ovalbumin (6.1 nm). The mean particle sizes of LDL and HDL in the calibrators were 25.3 and 11.3 nm, respectively, based on the calibration curve. The elution times of the observed peaks on a chromatogram were converted to particle sizes, using a linear calibration curve of the logarithm of the particle sizes plotted against the elution times corresponding to LDL and HDL in the calibrator. In this study, we used four HPLC systems (instruments A, B, S1, and S2) with different column-load numbers. The term "column-load number" indicates the number of samples injected into the columns. At the beginning of this study, the column-load numbers for each instrument were ϳ5000 (column nos. T9056 and T9057) for instrument A, 250 (column nos. 84SM2Y0005 and 84SM2Y0006) for B, 2000 (column nos. 84SM1Y0023 and 84SM1Y0024) for S1, and 2500 (column nos. T9091 and T9092) for S2. The HPLC method was performed at Tokyo Medical and Dental University with instruments A and B (in Tokyo and Chiba, respectively), and at SRL Inc., in Tokyo, with instruments S1 and S2. The same calibrator was used for all instruments. All samples were analyzed in duplicate.
cdc reference methods for tc and hdl-c
The reference method for cholesterol is the Abell-LevyBrodie-Kendall assay, as modified by the CDC, described previously in detail (13 ) . In this method, serum is saponified with ethanolic KOH and extracted with hexane. An aliquot of the extract is evaporated, and the residue is reacted with Liebermann-Burchard reagent to develop the color, which is measured at 620 nm.
The reference method for HDL-C consists of a threestep procedure involving ultracentrifugation, precipitation, and cholesterol analysis (14 ) . After triglyceride-rich lipoproteins are removed from the serum by ultracentrifugation against a solution with a density of 1.006 kg/L, apolipoprotein B-containing lipoproteins in the ultracentrifugal infranate are precipitated with heparin and MnCl 2 , and the cholesterol in the heparin-MnCl 2 supernatant is measured by the Abell-Kendall method at CDC.
The reference methods were performed in duplicate at OMC in Japan.
tg analysis
TG values were determined enzymatically in a single analysis with a Hitachi 7170 automated analyzer, using reagent kit L Type Wako TG-H (Wako Pure Chemical Industries). The TG assay was corrected for the presence of endogenous glycerol.
Results precision
The results of the precision studies are summarized in Table 1 . Two different materials (QC1 and QC2) with low (1370 mg/L) and high (2180 mg/L) TC concentrations were analyzed to assess the precision of the four HPLC systems. One aliquot of each pooled serum was assayed by each instrument in five replicates each day for 4 days and in duplicate each day for 16 days. The within-day variance (V within ) was determined as the mean of the daily variances at the first 4 days. The between-day variance (V between ) was determined as the variance (V) of the daily means at 20 days, which was adjusted for the within-day variance component; V between ϭ V Ϫ (V within /Number of repeats per day). Total variance (V total ) was the value of V within ϩ V between . At the low TC concentration (QC1), the total imprecision (CV) values for A, B, S1, and S2, respectively, were as follows: 1.5%, 2.7%, 1.6%, and 2.0% for TC; 1.9%, 3.3%, 2.0%, and 2.4% for HDL-C; 1.2%, 2.2%, 1.6%, and 1.4% for LDL-C; 2.3%, 5.2%, 4.5%, and 5.4% for VLDL-C; 12%, 19%, 43%, and 32% for CM-C; 0.35%, 0.37%, 0.39%, and 0.33% for LDL size; and 0.55%, 0.92%, 0.82%, and 0.43% for HDL size. At the high TC concentration (QC2), the total imprecision values for A, B, S1, and S2, respectively, were as follows: 1.7%, 1.8%, 0.8%, and 0.8% for TC; 2.8%, 2.8%, 0.9%, and 1.2% for HDL-C; 1.8%, 1.9%, 1.3%, and 1.5% for LDL-C; 2.5%, 4.7%, 4.2%, and 5.9% for VLDL-C; 17%, 11%, 37%, and 29% for CM-C; 0.37%, 0.39%, 0.50%, and 0.31% for LDL size; and 0.73%, 0.78%, 0.79%, and 0.41% for HDL size. Because the CM-C concentrations in the samples used were Ͻ7 mg/L, the CVs were relatively higher than for the other analytes; the SD for the CM-C assay was 0.4 -1.7 mg/L.
between-instrument comparison
Using four HPLC instruments and group-A samples (n ϭ 50), we estimated between-instrument variation for the measurement of lipoprotein cholesterol concentrations (TC, HDL-C, LDL-C, VLDL-C, and CM-C) and the particle sizes of LDL and HDL. To examine the degree of agreement among the values obtained by the four instruments, we calculated linear regression equations by Deming regression analysis and the absolute mean differences between each apparatus ( Table 2 Statistical differences as assessed by the Student paired t-test were not observed between the TC values obtained from instruments S1 and S2, between the HDL-C values obtained from B and S2, between the LDL-C values obtained from B, S1, and S2, and between CM-C values obtained from A and S2. For the VLDL-C, LDL size, and HDL size assays, the differences between the values obtained from the four instruments were significant (P Ͻ0.05) but slight. LDL and HDL were detected in all samples by all four instruments, but CM was detected in only 15 samples by A, 24 samples by B, 12 samples by S1, and 16 samples by S2. VLDL was not detected by any of the instruments.
Between-instrument imprecision values, which were calculated by an analysis of variance, were 1.9% for TC, 3.1% for HDL-C, 3.0% for LDL-C, 10% for VLDL-C, 49% for CM-C, 0.6% for LDL size, and 0.8% for HDL size. 
accuracy for tc and hdl-c
The results obtained for the TC assay with all four instruments and the reference method are shown in Fig. 2 and Table 3 . Linear regression analysis by the leastsquares method showed that only instrument B gave a slope that was significantly Ͼ1.0, but the intercepts did not differ significantly from 0 mg/L for any of the instruments. The estimated values at 2200 mg/L (the upper end of the reference interval), using the regression lines, were 2212 mg/L for A, 2222 mg/L for B, 2189 mg/L for S1, and 2195 mg/L for S2, which corresponded to 0.5%, 1.0%, Ϫ0.5%, and Ϫ0.2% bias, respectively. The mean biases for A, B, S1, and S2 were 0.3%, 1.2%, Ϫ0.6%, and Ϫ0.5%, respectively. The total error (%), which is equal to the systematic error [absolute mean bias (%)] plus the random error [total imprecision (%) ϫ 1.96], was 3.6% for A, 6.6% for B, 3.7% for S1, and 4.3% for S2 (Table 3) . Three instruments (A, B, and S1) were used for the comparison with the reference method for HDL-C. Group B samples (n ϭ 46) were analyzed using the same conditions as for the TC assay. The results are shown in Fig. 3 and Table 4 . Although the two methods correlated very well, with correlation coefficients of 0.996 -0.999, the slopes and intercepts of the regression lines were significantly different from 1.0 and 0 mg/L, respectively. The HPLC method overestimated HDL-C values at all points between 208 to 853 mg/L when compared with the reference method. Estimated values at 350 mg/L (the lower end of the reference interval), using the regression lines, were 396 mg/L (13.1% bias) for A, 381 mg/L (8.9% bias) for B, and 395 mg/L (12.9% bias) for S1. Mean biases of 12.3%, 8.4%, and 11.6% were found for instruments A, B, and S1, respectively, for the HDL-C assay. The total error was 17.2% for A, 15.0% for B, and 13.6% for S1.
tg interference
We used instrument A and group C samples (n ϭ 19) to assess the performance of the HPLC method for patients with a wide range of serum TG concentrations from 2110 to 53 200 mg/L. With one sample that had a TG concentration of 53 200 mg/L, the TC value was remarkably overestimated by the HPLC method relative to the refer- ence method: the TC values determined by the reference and HPLC methods were 2945 and 4306 mg/L, respectively. Because the bias of 46.2% (1361 mg/L) exceeded the sum of the mean bias plus SD multiplied by 3, the sample was excluded from all data analyses, although the reason for the discrepancy was not clear. In Fig. 4A , the reference (x) and HPLC (y) methods yield a linear regression line of y ϭ 1.06x Ϫ 152 (r ϭ 0.951; n ϭ 18) for TC assay. Fig. 5A , in which the biases vs the reference method are plotted as a function of serum TG concentrations, shows an increasingly negative bias (r ϭ Ϫ0.743; P Ͻ0.001) with increasing TG concentration. Samples from patients with high TG concentrations often give high VLDL-C and/or high CM-C values. Plotted as a function of CM-C concentration as determined by the HPLC method rather than serum TG concentrations, TC assay biases were inversely correlated (r ϭ Ϫ0.963: P Ͻ0.001) with CM-C concentrations (Fig. 5B) . Therefore, we assumed that the detection of CM-C might be incomplete in the HPLC method, which would lead to underestimation of TC. The mean bias, however, was 0.1% (6 mg/L) and small in an overall range of TG concentrations up to ϳ17 000 mg/L.
For the HDL-C assay, the reference (x) and HPLC (y) methods were highly correlated (r ϭ 0.985) and produced a linear regression line of y ϭ 1.04x ϩ 52.9 (n ϭ 18), as shown in Fig. 4B . The HPLC method gave a mean bias of 20.0% vs the reference method for group C samples, and the bias was positively higher than for samples with TG concentrations within the reference interval. Fig. 5C shows the HDL-C assay biases plotted as a function of serum TG concentrations, suggesting that there is correlation (r ϭ 0.720; P Ͻ0.001) between HDL-C assay bias and TG concentration. We also compared the HDL-C values obtained by the HPLC method from samples before and after ultracentrifugation at OMC (Table 5) . Although statistical analysis by the Student paired t-test gave a significantly higher (not lower) result after ultracentrifugation than before ultracentrifugation, the mean difference (HDL-C results after ultracentrifugation minus HDL-C results before ultracentrifugation) was very small (16 mg/L). If TG-rich lipoproteins of d Ͻ1.006 kg/L had made the HPLC method overestimate the HDL-C values, the results after ultracentrifugation would have been lower than those before ultracentrifugation. The HPLC method for HDL-C, therefore, was considered less affected by TG-rich lipoproteins.
Discussion
We and our colleagues have used HPLC to obtain lipoprotein profiles for serum or plasma samples from human and nonhuman subjects (15 ) . HPLC methods have been applied to the analysis of lipoproteins in low concentrations, such as the unbound lipoproteins present in the supernatants of mixtures of serum and immunoaffinity gels containing antibodies to apolipoproteins (16 ) , and secreted lipoproteins in the supernatants of HepG2 cell cultures or hepatocytes obtained from the Watanabe heritable hyperlipidemic rabbit (17 ) . The main advantages of the HPLC method are direct profiling of the lipoprotein cholesterol distribution in a small sample volume (5 L) without special techniques, and automatic calculation of the major lipoprotein cholesterol concentrations and particle sizes of LDL and HDL in a single analytical run of ϳ16 min. In Japan, some clinical laboratories have begun to use this method, and the need to assess the precision and accuracy of the HPLC method led to this study. It has been difficult to compare the HPLC method with the recommended reference methods because the reference methods require relatively large sample volumes and are time-consuming and labor-intensive. In addition, reference methods have not been established for VLDL-C, CM-C, LDL size, and HDL size. In the precision study, the four HPLC systems met the performance goals for measurement of TC (CV Ͻ3%), HDL-C (CV Ͻ4% at HDL-C Ͼ420 mg/L), and LDL-C (CV Ͻ4%) required by the recent National Cholesterol Education Program (NCEP) guidelines (18, 19 ) . It was, however, impossible to assess the precision of measurements of VLDL-C, CM-C, and particle sizes by the HPLC method because at present there are no NCEP guidelines for these assays. Our results did reveal that the HPLC method produced better precision (mean CV ϭ 4.6%) for the VLDL-C assay than the single vertical spin auto profiler (CV ϭ 4.8%) (20 ) and fast lipoprotein chromatography (CV ϭ 5.8%) (21 ) .
In our between-instrument comparison study, a small variation was found in determinations of lipoprotein cholesterol concentrations and particle sizes. However, we did not find a tendency for column-load numbers to have a direct effect on the lipoprotein profile. The precision remained high for column-load numbers in a wide range from ϳ250 to 5000.
According to the NCEP guidelines for TC measurements, the goals for total error and absolute mean bias are Յ8.9% and Յ3%, respectively (19 ) . The results in the accuracy study revealed that all HPLC systems, with columns with different column-load numbers, met the NCEP performance criteria for the TC assay when the same calibrator (lot no. 90920) was used, and suggested that the recovery of lipoproteins from columns was satisfactory. The NCEP performance goals for HDL-C require a total error of Յ13% and an absolute mean bias of Յ5% (18 ) . These criteria were not met by three HPLC systems, which had total errors Ն13.6% and absolute mean biases Ն8.4%. Considering the high precision of the HPLC method for HDL-C (CV Յ3.3% at HDL-C Ͼ420 mg/L), the disagreement between the reference and HPLC methods must have been caused by systematic error, not random error.
The ratio of HDL-C to TC in the calibrator was 36.9%, calculated from the reference values, whereas the ratio of HDL area to total area of the HPLC pattern obtained by the four instruments was 38.6% on average. All HPLC systems overestimated HDL-C in the calibrator, and this positive bias can in part explain the systematic error. When we calculated the HDL-C concentration using a linear calibration curve of the assigned HDL-C value plotted against the area corresponding to the HDL in the calibrator, the absolute mean bias was Ͻ5.2% instead of 12.3%.
Although we confirmed that the traceability of the HPLC method to the reference method for HDL-C was improved by use of the reference material mentioned above, the problem remains as to whether the HDL classified by HPLC is the same as the HDL classified by the reference method. The HDL separated by the HPLC (10 ) . On the other hand, heparin-Mn 2ϩ reagent is not likely to precipitate HDL subclasses such as apolipoprotein E-containing HDL particles (22 ) . Further studies with individual samples will be required to answer this question.
When TG concentrations were increased, the TC assay bias was acceptable, at Յ3%, with some exceptions: the HPLC method became negatively biased, especially in the presence of increasing CM-C concentrations. This finding indicates that the determination of CM-C by the HPLC method is incomplete, probably because of inadequate enzymatic detection of CM-C. On the other hand, HDL-C concentrations were significantly overestimated by the HPLC method compared with the reference method, and the positive bias was correlated with serum TG concentration. Ultracentrifugation to remove TG-rich lipoproteins prior to analysis, however, did not eliminate this problem. We therefore concluded that the HPLC method for HDL-C was affected only minimally by the presence of TG-rich lipoproteins.
Methods based on different principles will produce different values. Wiebe and Smith (23 ) described how it might be possible to adjust reagent concentrations, ionic strength, buffer pH, or other characteristics of the HDL isolation reagents so that the HDL-C values would mimic those obtained with another method. It is important in clinical sites that values obtained by new methods be close to the target values. In terms of standardization of HDL-C measurement, the accuracy should be based on the CDC reference method, which has yielded coronary heart disease risk estimations and population distributions.
In summary, the between-instrument variation in serum lipoprotein analysis by the HPLC method was confirmed to be very small. This method met the NCEP criteria for the TC assay. As for the HDL-C assay, the values obtained with the HPLC method were significantly higher than those obtained with the reference method, in spite of good correlation between the two methods. The reason for this difference is not clear at present. However, the HPLC method gives considerable information, such as size distribution of heterogeneous lipoproteins, in a chromatogram, as shown in Fig. 1 . We believe that additional information that other methods do not provide is present on the chromatogram. Analysis of the chromatogram for both quantitative and qualitative information may be useful for studies on the serum lipoproteins that play a vital role in the development of atherosclerosis.
